ABCG2 and chronic myelogenous leukemia, BCR-ABL1 positive: These results suggested that the expression of ABCG2 and the SP may be regulated by PTEN through the PI3K/Akt pathway, which would be a potentially effective strategy for targeting CML stem cells.